Antihypertensive agents which inhibit sympathetic activity: potentially adverse effects of combination treatment.
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects; D004359:Drug Therapy, Combination; D004837:Epinephrine / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D011311:Pressoreceptors / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects*
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D009638:Norepinephrine; D004837:Epinephrine